These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 30827358)

  • 21. [The active middle ear implant for the rehabilitation of sensorineural, mixed and conductive hearing losses].
    Sprinzl GM; Wolf-Magele A; Schnabl J; Koci V
    Laryngorhinootologie; 2011 Sep; 90(9):560-72. PubMed ID: 21913153
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A novel implantable hearing system with direct acoustic cochlear stimulation.
    Häusler R; Stieger C; Bernhard H; Kompis M
    Audiol Neurootol; 2008; 13(4):247-56. PubMed ID: 18259077
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Fitting recommendations and clinical benefit associated with use of the NAL-NL2 hearing-aid prescription in Nucleus cochlear implant recipients.
    English R; Plant K; Maciejczyk M; Cowan R
    Int J Audiol; 2016; 55 Suppl 2():S45-50. PubMed ID: 26853233
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Vibrant Soundbridge middle ear implant in mixed hearing loss. Indications, techniques, results.
    Dumon T; Gratacap B; Firmin F; Vincent R; Pialoux R; Casse B; Firmin B
    Rev Laryngol Otol Rhinol (Bord); 2009; 130(2):75-81. PubMed ID: 19813468
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Fully implantable middle ear implant--indications, surgical technique and first results].
    Niemczyk K; Morawski K; Lachowska M; Bartoszewicz R; Sokołowski J; Karchier E
    Otolaryngol Pol; 2011; 65(3):236-40. PubMed ID: 21916227
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The expanding domain of implantable hearing devices: an update on current status in the United States.
    Spitzer JB; Fayad JN; Wazen JJ
    Rev Laryngol Otol Rhinol (Bord); 2003; 124(1):39-44. PubMed ID: 12934441
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Use of the Carina active middle ear implant in otosclerosis patients].
    Didczuneit-Sandhop B; Langer J
    HNO; 2021 Oct; 69(10):828-834. PubMed ID: 33415345
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Retrospective audiological analysis of bone conduction versus round window vibratory stimulation in patients with mixed hearing loss.
    Mojallal H; Schwab B; Hinze AL; Giere T; Lenarz T
    Int J Audiol; 2015 Jun; 54(6):391-400. PubMed ID: 25735204
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Systematic and audiological indication criteria for bone conduction devices and active middle ear implants.
    Rahne T; Plontke SK
    Hear Res; 2022 Aug; 421():108424. PubMed ID: 34987018
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Consensus Statement on Bone Conduction Devices and Active Middle Ear Implants in Conductive and Mixed Hearing Loss.
    Otol Neurotol; 2022 Jun; 43(5):513-529. PubMed ID: 35383700
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Measurement of implant stability and auditory pure-tone thresholds of Baha patients comparing osteosysthesis and osseointegrated systems.
    Rahne T; Götze G; Pein MK
    Z Med Phys; 2015 Mar; 25(1):19-24. PubMed ID: 25063386
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Achondroplasia and severe sensorineural hearing loss: The role of active bone conduction implants.
    Siegel L; Araslanova R; Stepniak C; Zimmerman K; Agrawal SK
    Cochlear Implants Int; 2022 Sep; 23(5):291-299. PubMed ID: 35577761
    [TBL] [Abstract][Full Text] [Related]  

  • 33. An Implantable Hearing System As Rehabilitation for Hearing Loss Due to Bilateral Aural Atresia: Surgical Technique and Audiological Results.
    Brito R; Pozzobom Ventura LM; Jorge JC; Oliveira EB; Manzoni Lourencone LF
    J Int Adv Otol; 2016 Dec; 12(3):241-246. PubMed ID: 28031155
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Psychosocial Development in 5-Year-Old Children With Hearing Loss Using Hearing Aids or Cochlear Implants.
    Wong CL; Ching TYC; Cupples L; Button L; Leigh G; Marnane V; Whitfield J; Gunnourie M; Martin L
    Trends Hear; 2017; 21():2331216517710373. PubMed ID: 28752809
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Passive and active middle ear implants].
    Beutner D; Hüttenbrink KB
    Laryngorhinootologie; 2009 May; 88 Suppl 1():S32-47. PubMed ID: 19353457
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Utility of bilateral acoustic hearing in combination with electrical stimulation provided by the cochlear implant.
    Plant K; Babic L
    Int J Audiol; 2016; 55 Suppl 2():S31-8. PubMed ID: 26987051
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Bioelectronic options for a totally implantable hearing device for partial and total hearing loss.
    Maniglia AJ; Murray G; Arnold JE; Ko WH
    Otolaryngol Clin North Am; 2001 Apr; 34(2):469-83. PubMed ID: 11382582
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Active middle ear implantation for patients with sensorineural hearing loss and external otitis: long-term outcome in patient satisfaction.
    Zwartenkot JW; Hashemi J; Cremers CW; Mulder JJ; Snik AF
    Otol Neurotol; 2013 Jul; 34(5):855-61. PubMed ID: 23739560
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Active hearing implants in chronic otitis media].
    Lailach S; Müller C; Lasurashvili N; Seidler H; Zahnert T
    HNO; 2021 Jun; 69(6):447-463. PubMed ID: 31712875
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Patient Outcomes in Magnet-Based Implantable Auditory Assist Devices.
    O'Niel MB; Runge CL; Friedland DR; Kerschner JE
    JAMA Otolaryngol Head Neck Surg; 2014 Jun; 140(6):513-20. PubMed ID: 24763485
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.